Clinical Trial Update: Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with metronomic chemotherapy, diet, and exercise after preoperative chemotherapy for breast cancer; study terminated with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-01-19